TABLE 3.

Technical Support Visit and Mystery Client Visit Data Comparison: Counseling on Injectable Contraceptives

Mystery Client VisitTechnical Support VisitKnow-Do Gap

%

(95% Confidence Interval)

N

%

(95% Confidence Interval)

Na

%

(95% Confidence Interval)

Provider explained how to use this method83.8 (81.9, 85.5)40198.9 (98.0, 99.5)18616.4b (10.3, 22.5)
Provider mentioned the side effects of this method93.8 (92.1, 95.1)40193.3 (91.8, 94.5)409−0.6 (−2.6, 1.3)
Provider mentioned what to do if you experience side effects while using this method94.0 (92.4, 95.3)40193.3 (91.7, 94.7)409−0.8 (−2.8, 1.2)
Provider mentioned advantages of method63.4 (60.6, 66.1)40196.4 (94.6, 97.6)22337.8b (33.4, 42.2)
Provider mentioned disadvantages of this method95.2 (93.7, 96.3)40197.5 (95.7, 98.6)2232.4c (0.1, 4.8)
  • a The number of observations varies for the TSV data because the TSV checklist was revised during the period in which TSVs analyzed for this study were collected. Consequently, although we compared the same 414 facilities, the TSV denominator for certain questions was less than 414 because the previous version of the TSV checklist did not have a comparable variable to the mystery client survey for those questions.

  • bP<.001; P-values calculated using t-test on paired values; N is the number of observations.

  • cP<.05.